Tag: Emerging Cancer Diagnostics Market

Emerging Cancer Diagnostics Market Drivers And Trends The Emerging Cancer Diagnostics Market was valued at USD 23.8 Billion in 2022 and is projected to reach USD 50.6 Billion by 2030, growing at a CAGR of 10.1% from 2024 to 2030. Increasing global cancer prevalence, along with advancements in diagnostic technologies, such as liquid biopsy, molecular […]